Biopharmadive.com - SEO Checker

Overview of the SEO Check
Meta information
80% 
Page quality
83% 
Page structure
29% 
Link structure
51% 
Server
78% 
External factors
100% 
SEO Score
Response time
0.87 s
File size
287.90 kB
Words
1855
Media files
111
Number of links
138 internal / 28 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Biotech and Pharma Industry News | BioPharma Dive
The length of the page title is perfect. (477 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
The meta description is too long: 1365 pixels from max. 1000 pixels. Optimize description
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
No canonical link is specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en-us
Server location: Canada
The following language is defined by HTML: en-us
Alternate/Hreflang Links
(Somewhat important)
There are no alternate links specified on this page.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportwidth=device-width, initial-scale=1.0
descriptionBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
msapplication-TileImage/mstile-150x150.png?v=3
msapplication-TileColor#603cba
theme-color#ffffff
langen-us
fb:pages398644486955359
og:titleBiotech and Pharma Industry News | BioPharma Dive
og:descriptionBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
og:imagehttps://d12v9rtnomnebu.cloudfront.net/divesite/header_image_logos/biopharma_dive_feed_header.jpg
x-ua-compatibleie=edge
charsetutf-8

Automatically check biopharmadive.com including all subpages at once!

Try for free
Guaranteed free of charge during trial period.

Page quality

Content
(Critically important)
Words from the H1 heading are not used in the page content.
This page contains 1855 words. That's ok.
27.4% of the text are stop words.
Keywords used in the page title are also used in the page content. That's good!
The page contains a listing, which indicates a good text layout.
29 paragraphs were found on this page.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 16.7 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
A viewport "width=device-width, initial-scale=1.0" is provided.
At least one Apple touch icon is specified.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 37 tags for this page.
Image SEO
(Somewhat important)
5 images have no alt attribute. The content of alt attributes is used by search engines.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
...et/logo/publications/biopharma_black.svgBioPharma Dive
...et/logo/publications/biopharma_black.svgBioPharma Dive
...tic/img/menu_icons/menu.svg?273117231121menu
...c/img/menu_icons/search.svg?320116291121search
...ic/img/email_icons/mail.svg?273117231121No alt attribute provided
...c/img/menu_icons/search.svg?320116291121search
...ic/img/menu_icons/close.svg?273117231121close search
...WdlL2RpdmVpbWFnZS9lbmhlcnR1LmpwZw==.webpEnhertu
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WFnZS9NQV9oZWFkZXJfZVVpQk81cy5wbmc=.webpAn illustration for BioPharma Dive's deals database
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...W1hZ2VfMTA0MHg2MTZfa2NZMmh5Zy5wbmc=.webpA Young woman standing on the platform of a train station
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WdlL2RpdmVpbWFnZS9OQTJfMTQ1Ni5qcGc=.webpPhysicians, researchers and healthcare professionals attend ASCO's annual Meeting on June 2, 2023 in Chicago.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMDI1ODM3NzM4LmpwZw==.webpA large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webpA stack of newspapers are seen against a blue background.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjI3NzEwNDk4LmpwZw==.webpNo alt attribute provided
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMjAyMTI1MjYzLmpwZw==.webpA person in a blue suit gestures while seated at a conference table.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNzMyMDUyNTc5LmpwZw==.webpSpermatozoon is injected into an ovum with help of microneedle and holding pipette underneath a microscope
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjg4NjcwMjY5LmpwZw==.webpThe Moderna headquarters is seen on November 30, 2020 in Cambridge, Massachusetts.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMjA5Nzg3ODAxLmpwZw==.webpA sign spelling Roche hangs on the side of a building.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMjAzNjI4MTU5XzIuanBn.webpFDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...W90ZWNoLWlwb3RyYWNrZXJoZWFkZXIucG5n.webpA stylized illustration of test tubes in front of a red line on a chart going up and to the right.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webpA stack of newspapers are seen against a blue background.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WFnZS9QZml6ZXJfSFFfRW50cmFuY2UuanBn.webpPfizer HQ entrance
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xOTc4MjM1MzE3LmpwZw==.webp23andMe
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...F9Hb3R0ZXNkaWVuZXJfakplSWV6Sy5qcGc=.webpA person in a white shirt sits in an office for a photograph.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WFnZS9wYXRlbnRfdGhpY2tldF80LnBuZw==.webpA stylized illustration of a "patent thicket" for Jonathan Gardner's Nov. 1 story on Amgen's Enbrel.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...2RpdmVpbWFnZS9GREFfSFFfR2V0dHkuanBn.webpThe headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjM4ODMwMjMyLmpwZw==.webpA worker prepares ampoules of the Nuvaxovid vaccine against Covid-19 by Novavax in Berlin, Germany in February 2022.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webpA stack of newspapers are seen against a blue background.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMTc0MjA0OTkxLmpwZw==.webpA person in a suit sits at a desk with a microphone.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjg5Nzg0NjQwLmpwZw==.webpA white office building bearing a sign for BioMarin Pharmaceutical stands against a blue sky.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...Wdlcy0xMjI3NzEwNDk4X3pJUnRuUlcuanBn.webpFDA
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...TY5MDc4MzcxMl8yYTc1ZmQ5M2MyX28uanBn.webpA photo of Sanofi headquarters in Paris, France.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...mJWaWVfVVNfSGVhZHF1YXJ0ZXJzLmpwZw==.webpAn AbbVie sign is seen on a building at the pharmaceutical company's U.S. headquarters.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMTk5NDI3NjE2LmpwZw==.webpSen. Chuck Grassley gestures as he speaks during a committee meeting.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...nts/buttons/right-arrow.svg?353714160519next icon
...XR0eUltYWdlcy0xOTc4MjM1MzE3LmpwZw==.webp23andMe
...XR0eUltYWdlcy0yMjAzNjI4MTU5XzIuanBn.webpFDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
...F9Hb3R0ZXNkaWVuZXJfakplSWV6Sy5qcGc=.webpA person in a white shirt sits in an office for a photograph.
...2RpdmVpbWFnZS9GREFfSFFfR2V0dHkuanBn.webpThe headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
...lib_icons/webinar-black.svg?141716111021studioID resource icon
...ib_icons/playbook-black.svg?141716111021studioID resource icon
...ib_icons/playbook-black.svg?141716111021studioID resource icon
...ars-focus-rare-disease-grows-2025-05-22/No alt attribute provided
/static/img/offsite.svg?141716111021offsite link
...y/rfk-jr-maha-commission-report-5c13696dNo alt attribute provided
/static/img/offsite.svg?141716111021offsite link
...-trump-medicaid-coverage-south-carolina/No alt attribute provided
/static/img/offsite.svg?141716111021offsite link
/static/img/signup-dive.png?080016020822Daily Dive newsletter example
...oudfront.net/logo/corporate/ID_black.svgIndustry Dive Logo
...s/article_page/linkedin.svg?092716141024linkedin icon
...s/article_page/facebook.svg?440116200824facebook icon
...al_icons/article_page/x.svg?092716141024x icon
..._icons/article_page/rss.svg?440116200824rss feed icon
...ic/img/menu_icons/close.svg?273117231121close menu
...c/img/menu_icons/search.svg?320116291121search
...menu_icons/chevron_down.svg?410116200325down arrow

Page structure

H1 heading
(Critically important)
Don't miss tomorrow's biopharma industry news
Too many H1 headings
Headings
(Important)
There are 47 headings on the page. The amount of headings should be in a more proper relation to the amount of text.

Heading structure

Heading levelContent
H1 Don't miss tomorrow's biopharma industry news
H1 AI tool could help doctors ID breast cancers vulnerable to Enhertu
H2 Top stories
H2 The Latest
H3 FDA panel recommends keeping COVID shots targeted to same strain as last year
H3 Sanofi gains experimental Alzheimer’s drug through Vigil buyout
H3 A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases
H3 Women’s health faces growing headwinds, despite jump in venture investment
H3 Facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously
H3 Biotech’s M&A outlook is uncertain. Track the deals that are happening here.
H3 From insight to impact: How eCOAs strengthen trial data quality
H3 Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer
H3 Novo pressures GLP-1 compounders as FDA ban takes hold
H3 FDA advisers pan Pfizer’s PARP drug; Sarepta to resume Duchenne study
H3 FDA panel backs Darzalex for early stage multiple myeloma
H3 The Trump administration is remaking HHS. Track the changes here.
H3 Reproductive health startup raises $65M for infertility drugs
H3 Moderna pulls application for combo COVID, flu shot
H3 Roche strikes second Orionis deal to develop ‘molecular glues’ for cancer
H3 FDA sets stricter approval standards for COVID vaccines
H3 Biotech startups are built on venture capital. Track funding rounds here.
H3 Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff
H3 Pfizer buys into PD-1/VEGF competition with 3SBio deal
H3 Regeneron wins bid to buy 23andMe out of bankruptcy
H3 Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
H3 Drug patents protect pharma profits. Track when they’ll expire.
H3 FDA OKs first blood test to aid Alzheimer’s diagnosis
H3 Novavax’s COVID vaccine gets FDA approval, but with limits
H3 Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff
H3 Novo CEO to depart as obesity drugmaker’s challenges rise
H3 BioMarin to buy rare disease drugmaker Inozyme for $270M
H3 FDA delays approval decision for Biohaven rare disease drug
H3 Sanofi to pour more than $20B into US drug research and manufacturing
H3 AbbVie stakes $335M on a startup’s RNAi drugs
H3 Stopping a ‘moral obscenity’: Senate Judiciary Committee expresses support for PBM reform
H3 Get the free newsletter
H3 Most Popular
H3 Library resources
H3 Company Announcements
H3 What We're Reading
H3 Events
H3 Industry Intel
H3 BioPharma Dive news delivered to your inbox
H3 Get BioPharma Dive in your inbox
H4 Explore
H4 Reach our audience
H4 Related Publications
Some internal links have dynamic parameters. All internal URLs, which are not marked as nofollow, should not contain dynamic parameters.
Some anchor texts are used more than once.
1 links don't have an anchor text.
The number of internal links is ok.
None of the anchor texts is too long.
There are too many external links (28) on this page.
LinkAttributesAnchor text
https://www.biopharmadive.com/Anchor Skip to main content
https://www.techtarget.com/ter...New window External Subdomain Terms of Use
https://www.techtarget.com/pri...New window External Subdomain Privacy Policy
https://www.biopharmadive.com/IMG-ALT BioPharma Dive
/deep-dive/Deep Dive
/library/Library
/events/Events
/press-release/Press Releases
/signup/?signup_location=headerNofollow Sign up
/signup/?signup_location=headerNofollow Text duplicate Sign up
/topic/pharma/Pharma
/topic/biotech/Biotech
/topic/fda/FDA
/topic/clinical-trials/Clinical Trials
/topic/deals/Deals
/topic/drug-pricing/Drug Pricing
/topic/gene-therapy/Gene Therapy
/news/her2-breast-cancer-diagn...IMG-ALT Enhertu
/news/her2-breast-cancer-diagn...AI tool could help doctors ID breast cancers vulnerable to Enhertu
/news/her2-breast-cancer-diagn...Read more ➔
/news/fda-covid-vaccine-advise...FDA panel recommends keeping COVID shots targeted to same strain as last year
/news/sanofi-vigil-acquisition...Sanofi gains experimental Alzheimer’s drug through Vigil buyout
/news/crispr-n-of-1-gene-editi...A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases
/news/womens-health-venture-fu...Women’s health faces growing headwinds, despite jump in venture investment
/news/deals-pharma-biotech-mar...Facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously
/news/biotech-pharma-deals-mer...IMG-ALT An illustration for BioPharma Dive's deals database
/news/biotech-pharma-deals-mer...Biotech’s M&A outlook is uncertain. Track the deals that are happening here.
/topic/deals/Text duplicate Deals
/spons/from-insight-to-impact-...IMG-ALT A Young woman standing on the platform of a train station
/spons/from-insight-to-impact-...From insight to impact: How eCOAs strengthen trial data quality
/topic/clinical-trials/Text duplicate Clinical Trials
/news/zepzelca-tecentriq-small...IMG-ALT Physicians, researchers and healthcare professionals attend ASCO's annual Meeting on June 2, 2023 in Chicago.
/news/zepzelca-tecentriq-small...Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer
/topic/pharma/Text duplicate Pharma
/news/novo-access-wegovy-glp-1...IMG-ALT A large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
/news/novo-access-wegovy-glp-1...Novo pressures GLP-1 compounders as FDA ban takes hold
/topic/manufacturing/Manufacturing
/news/pfizer-talzenna-prostate...IMG-ALT A stack of newspapers are seen against a blue background.
/news/pfizer-talzenna-prostate...FDA advisers pan Pfizer’s PARP drug; Sarepta to resume Duchenne study
/topic/pharma/Text duplicate Pharma
/news/fda-panel-backs-darzalex...No Text
/news/fda-panel-backs-darzalex...FDA panel backs Darzalex for early stage multiple myeloma
/topic/pharma/Text duplicate Pharma
/news/hhs-fda-restructuring-la...IMG-ALT A person in a blue suit gestures while seated at a conference table.
/news/hhs-fda-restructuring-la...The Trump administration is remaking HHS. Track the changes here.
/topic/pharma/Text duplicate Pharma
/news/repronovo-series-a-ferti...IMG-ALT Spermatozoon is injected into an ovum with help of microneedle and holding pipette underneath a microscope
/news/repronovo-series-a-ferti...Reproductive health startup raises $65M for infertility drugs
/topic/biotech/Text duplicate Biotech
/news/moderna-withdraw-fda-cov...IMG-ALT The Moderna headquarters is seen on November 30, 2020 in Cambridge, Massachusetts.
/news/moderna-withdraw-fda-cov...Moderna pulls application for combo COVID, flu shot
/topic/biotech/Text duplicate Biotech
/news/roche-orionis-molecular-...IMG-ALT A sign spelling Roche hangs on the side of a building.
/news/roche-orionis-molecular-...Roche strikes second Orionis deal to develop ‘molecular glues’ for cancer
/topic/biotech/Text duplicate Biotech
/news/fda-covid-booster-approv...IMG-ALT FDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
/news/fda-covid-booster-approv...FDA sets stricter approval standards for COVID vaccines
/topic/fda/Text duplicate FDA
/news/biotech-venture-capital-...IMG-ALT A stylized illustration of test tubes in front of a red line on a chart going up and to the right.
/news/biotech-venture-capital-...Biotech startups are built on venture capital. Track funding rounds here.
/topic/biotech/Text duplicate Biotech
/news/tourmaline-pacibekitug-s...Text duplicate IMG-ALT A stack of newspapers are seen against a blue background.
/news/tourmaline-pacibekitug-s...Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff
/topic/pharma/Text duplicate Pharma
/news/pfizer-3sbio-pd1-vegf-ca...IMG-ALT Pfizer HQ entrance
/news/pfizer-3sbio-pd1-vegf-ca...Pfizer buys into PD-1/VEGF competition with 3SBio deal
/topic/pharma/Text duplicate Pharma
/news/regeneron-23andme-acquir...IMG-ALT 23andMe
/news/regeneron-23andme-acquir...Regeneron wins bid to buy 23andMe out of bankruptcy
/topic/biotech/Text duplicate Biotech
/news/prime-medicine-restructu...IMG-ALT A person in a white shirt sits in an office for a photograph.
/news/prime-medicine-restructu...Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
/topic/biotech/Text duplicate Biotech
/news/patent-cliff-pharmaceuti...IMG-ALT A stylized illustration of a "patent thicket" for Jonathan Gardner's Nov. 1 story on Amgen's Enbrel.
/news/patent-cliff-pharmaceuti...Drug patents protect pharma profits. Track when they’ll expire.
/topic/pharma/Text duplicate Pharma
/news/fda-blood-test-alzheimer...IMG-ALT The headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
/news/fda-blood-test-alzheimer...FDA OKs first blood test to aid Alzheimer’s diagnosis
/topic/marketing/Marketing
/news/novavax-covid-vaccine-fd...IMG-ALT A worker prepares ampoules of the Nuvaxovid vaccine against Covid-19 by Novavax in Berlin, Germany in February 2022.
/news/novavax-covid-vaccine-fd...Novavax’s COVID vaccine gets FDA approval, but with limits
/topic/biotech/Text duplicate Biotech
/news/regeneron-amgen-pcsk9-tr...Text duplicate IMG-ALT A stack of newspapers are seen against a blue background.
/news/regeneron-amgen-pcsk9-tr...Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff
/topic/pharma/Text duplicate Pharma
/news/novo-nordisk-ceo-step-do...IMG-ALT A person in a suit sits at a desk with a microphone.
/news/novo-nordisk-ceo-step-do...Novo CEO to depart as obesity drugmaker’s challenges rise
/topic/pharma/Text duplicate Pharma
/news/biomarin-inozyme-acquisi...IMG-ALT A white office building bearing a sign for BioMarin Pharmaceutical stands against a blue sky.
/news/biomarin-inozyme-acquisi...BioMarin to buy rare disease drugmaker Inozyme for $270M
/topic/deals/Text duplicate Deals
/news/biohaven-fda-drug-approv...Text duplicate IMG-ALT FDA
/news/biohaven-fda-drug-approv...FDA delays approval decision for Biohaven rare disease drug
/topic/biotech/Text duplicate Biotech
/news/sanofi-11-billion-us-dru...IMG-ALT A photo of Sanofi headquarters in Paris, France.
/news/sanofi-11-billion-us-dru...Sanofi to pour more than $20B into US drug research and manufacturing
/topic/manufacturing/Text duplicate Manufacturing
/news/abbvie-adarx-rna-interfe...IMG-ALT An AbbVie sign is seen on a building at the pharmaceutical company's U.S. headquarters.
/news/abbvie-adarx-rna-interfe...AbbVie stakes $335M on a startup’s RNAi drugs
/topic/biotech/Text duplicate Biotech
/news/senate-judiciary-backs-p...IMG-ALT Sen. Chuck Grassley gestures as he speaks during a committee meeting.
/news/senate-judiciary-backs-p...Stopping a ‘moral obscenity’: Senate Judiciary Committee expresses support for PBM reform
/topic/pharma/Text duplicate Pharma
/?page=2More stories
IMG-ALT next icon
https://www.techtarget.com/ter...New window External Subdomain Text duplicate Terms of Use
https://www.techtarget.com/pri...New window External Subdomain Text duplicate Privacy Policy
/news/regeneron-23andme-acquir...Text duplicate IMG-ALT 23andMe
/news/regeneron-23andme-acquir...Text duplicate Regeneron wins bid to buy 23andMe out of bankruptcy
/news/fda-covid-booster-approv...Text duplicate IMG-ALT FDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
/news/fda-covid-booster-approv...Text duplicate FDA sets stricter approval standards for COVID vaccines
/news/prime-medicine-restructu...Text duplicate IMG-ALT A person in a white shirt sits in an office for a photograph.
/news/prime-medicine-restructu...Text duplicate Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
/news/fda-blood-test-alzheimer...Text duplicate IMG-ALT The headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
/news/fda-blood-test-alzheimer...Text duplicate FDA OKs first blood test to aid Alzheimer’s diagnosis
http://resources.industrydive....New window External Subdomain Scaling Smarter: How a Modern Tech Stack Fuels Diagnostic Lab Growth
https://biopharmadive.tradepub...New window External Subdomain Supporting Patient Safety Through Supply Chain Management
https://biopharmadive.tradepub...New window External Subdomain How Each Step in a Clinical Trial Fuels the Next
/library/View all
/press-release/Text duplicate View all
/press-release/get-started/Post a press release
https://www.reuters.com/busine...New window External Subdomain Prices for new US drugs doubled in 4 years as focus on rare disease grows
IMG-ALT offsite link
https://www.wsj.com/politics/p...New window External Subdomain What’s Inside RFK Jr.’s MAHA Report
IMG-ALT offsite link
https://kffhealthnews.org/news...New window External Trump Won’t Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
IMG-ALT offsite link
/what-we-are-readingText duplicate View all
https://events.industrydive.co...New window External Subdomain State of Oncology Research
/selfservice/event-listings/co...Promote an event
http://resources.industrydive....New window External Subdomain Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance
http://resources.industrydive....New window External Subdomain Unlock the Potential of Life Sciences and Health Systems Partnerships
https://resources.industrydive...New window External Subdomain Top Ways that AI Will Change Life Sciences
https://www.techtarget.com/ter...New window External Subdomain Text duplicate Terms of Use
https://www.techtarget.com/pri...New window External Subdomain Text duplicate Privacy Policy
https://www.industrydive.com/External Subdomain IMG-ALT Industry Dive Logo
https://www.linkedin.com/compa...External Subdomain IMG-ALT linkedin icon
https://www.facebook.com/bioph...External Subdomain IMG-ALT facebook icon
https://twitter.com/BioPharmaDiveExternal IMG-ALT x icon
/feeds/news/Subdomain IMG-ALT rss feed icon
/about/About
/editors/Editorial Team
/contact/Contact Us
/signup/?signup_location=foote...Nofollow Newsletter
/selfservice/article-licensing...Nofollow Purchase Licensing Rights
/press-release/Text duplicate Press Releases
/what-we-are-reading/What We're Reading
/advertise/Advertising
/press-release/get-started/Text duplicate Post a press release
/selfservice/event-listings/co...Text duplicate Promote an event
https://www.healthcaredive.com/External Subdomain Healthcare Dive
https://www.medtechdive.com/External Subdomain MedTech Dive
https://www.industrydive.com/i...External Subdomain other publications
https://www.techtarget.com/pri...External Subdomain Privacy policy
https://www.techtarget.com/ter...External Subdomain Terms of use
https://www.industrydive.com/t...External Subdomain Take down policy
https://www.biopharmadive.com/Home
/topic/pharma/Text duplicate Pharma
/topic/biotech/Text duplicate Biotech
/topic/fda/Text duplicate FDA
/topic/clinical-trials/Text duplicate Clinical Trials
/topic/deals/Text duplicate Deals
/topic/drug-pricing/Text duplicate Drug Pricing
/topic/gene-therapy/Text duplicate Gene Therapy
/deep-dive/Text duplicate Deep Dive
/library/Text duplicate Library
/events/Text duplicate Events
/press-release/Text duplicate Press Releases
https://www.techtarget.com/ter...New window External Subdomain Text duplicate Terms of Use
https://www.techtarget.com/pri...New window External Subdomain Text duplicate Privacy Policy

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.biopharmadive.com/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
The web server transmits the web page (HTML) in compressed form.
Performance
(Somewhat important)
The page response time of 0.87 seconds is longer than the recommended limit of 0.4 seconds. A high response time unnecessarily slows down search engine crawling and results in bad user experience as well.
The file size of the HTML document is fine (288 kB).

HTTP Response Header

NameValue
dateSun, 25 May 2025 09:24:08 GMT
content-typetext/html; charset=utf-8
sniply-optionsBLOCK
expiresSun, 25 May 2025 09:25:56 GMT
cache-controlmax-age=120
strict-transport-securitymax-age=31536000; includeSubDomains
x-locationEU
varyCookie, Accept-Encoding
x-varnish209497833 207478037
age11
via1.1 varnish (Varnish/7.1)
cf-cache-statusDYNAMIC
set-cookie283 Characters
servercloudflare
cf-ray9453fa5ebe686ee7-CDG
content-encodingbr
alt-svch3=":443"; ma=86400
statuscode200
http_versionHTTP/2

External factors

This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 213 referring domains.
This page has 49,401 backlinks.
This page has backlinks from 187 different ip addresses.

Robots.txt

#
#                ..;coxkOOOOOOkxoc;'.
#             .:d0NWMMMMMMMMMMMMMMWN0xc'
#          .:kXMMMMMMMMMMMMMMMMMMMMMMMXl.
#        .c0WMMMMMMMMMMMMMMMMMMMMMMMXd'
#       ,OWMMMMMMMMMMMMMMMMMMMMMMMXo'       ..
#      cXMMMMMMXo::::::::::::::col.       .lKXl.
#     lNMMMMMMM0'                       .lKWMMNo
#    :XMMMMMMMM0'                     .l0WMMMMMNc
#   .OMMMMMMMMM0'     .ccccccc;.      ,KMMMMMMMMO.
#   :NMMMMMMMMM0'     oWMMMMMMWKc.     oWMMMMMMMN:
#   lWMMMMMMMMM0'     oWMMMMMMMMX:     ,KMMMMMMMMo
#   oMMMMMMMMMM0'     oWMMMMMMMMNc     ,KMMMMMMMMd
#   cNMMMMMMMMM0'     oWMMMMMMMNd.     lWMMMMMMMWl
#   '0MMMMMMMMWk.     ,oooooooc'      ,0MMMMMMMMK,
#    oWMMMMMMXo.                     ,0MMMMMMMMWo
#    .xWMMMXd'                     ,dXMMMMMMMMWk.
#     .xWNx'       .',''''''',,;coONMMMMMMMMMWk.
#      .:,       .l0WWWWWWWWWWWMMMMMMMMMMMMMNd.
#              .lKWMMMMMMMMMMMMMMMMMMMMMMMWk;
#            .lKWMMMMMMMMMMMMMMMMMMMMMMMNk;.
#            .ckXWMMMMMMMMMMMMMMMMMMWXkl'
#               .;ldO0XNWWWWWWNXKOxl;.
#                    ..'',,,,''..
#
#

# NOTE: Allow is a non-standard directive for robots.txt. It is allowed by Google bots. See https://developers.google.com/search/reference/robots_txt#allow

User-agent: *
# Crawl delay asks bots to wait this many seconds between requests. Ignored by google.
Crawl-delay: 5
Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

# don't index our dynamic images
Disallow: /user_media/
Disallow: /imgproxy/

# don't deep index topic pages
Disallow: /topic/?page=*

Allow: /sitemap.xml

#
# Rules for specific crawlers below. Note that these don't stack. If you create a specific user-agent rule
# you should copy the rules over from '*' above by hand.
#

# Allow Twitter to see all links
User-agent: Twitterbot
Crawl-delay: 5
Disallow:

# Allow Googlebot-News to see header images and favicons, BUT make it follow all the directives from our * group
# See below link for why we have to repeat these directives
# https://developers.google.com/search/reference/robots_txt#order-of-precedence-for-user-agents
User-agent: Googlebot-News
Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

Allow: /google_news_sitemap.xml
# Allow Google News to see header images and favicons
Allow: /user_media/
Allow: /imgproxy/
Allow: /static/images/favicons


# Googlebot-Image is now used for favicons. Allow it to see favicon-related files but nothing else
User-agent: Googlebot-Image
Disallow: /
Allow: /imgproxy/
Allow: /static/images/favicons
Allow: /favicon.ico
Allow: /white-favicon.ico
Allow: /apple-touch-icon.png
Allow: /favicon-32x32.png
Allow: /white-favicon-32x32.png
Allow: /favicon-16x16.png
Allow: /white-favicon-16x16.png
Allow: /site.webmanifest
Allow: /safari-pinned-tab.svg
Allow: /browserconfig.xml
Allow: /android-chrome-144x144.png
Allow: /mstile-150x150.png

# Don't let PetalBot crawl at all
User-agent: PetalBot
Disallow: /

# Block ChatGPT bot https://platform.openai.com/docs/gptbot
User-agent: GPTBot
Disallow: /

# Block sentione.com
User-agent: sentibot
Disallow: /

# block seoclarity.net/bot.html
User-agent: claritybot
Disallow: /

# block omgili.com/crawler.html
User-Agent: omgilibot
Disallow: /
User-Agent: omgili
Disallow: /

# All Facebook crawler user-agent to see all
User-agent: facebookexternalhit/1.1
Disallow:

User-agent: AhrefsBot
# We want this bot to crawl way slower https://ahrefs.com/robot/
Crawl-Delay: 30

Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

# don't index our dynamic images
Disallow: /user_media/
Disallow: /imgproxy/

Disallow: /topic/
Disallow: /editors/

User-agent: Amazonbot
# Restrict what Amazonbot (Alexa) can see, and a
Crawl-Delay: 10

Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

# don't index our dynamic images
Disallow: /user_media/
Disallow: /imgproxy/

Disallow: /topic/
Disallow: /editors/
Disallow: /signup/*
Allow: /signup/$

User-agent: amazon-QBusiness    # Amazon Q Web Crawler
Disallow: /

User-agent: amazon-kendra # Amazon Kendra Web Crawler
Disallow: /

Search preview

www.biopharmadive.com
Biotech and Pharma Industry News | BioPharma Dive
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Pharma93%Check
biopharma92%Check
BioPharma Dive87%Check
news81%Check
Dive80%Check
Pharma Industry80%Check
Pharma Industry News80%Check
Biotech Pharma79%Check
Industry News74%Check
industry68%Check

Automatically check biopharmadive.com including all subpages at once!

Try for free
Guaranteed free of charge during trial period.

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions